These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 9475485)
1. Nitric oxide in sepsis-syndrome: potential treatment of septic shock by nitric oxide synthase antagonists. Ketteler M; Cetto C; Kirdorf M; Jeschke GS; Schäfer JH; Distler A Kidney Int Suppl; 1998 Feb; 64():S27-30. PubMed ID: 9475485 [TBL] [Abstract][Full Text] [Related]
2. [Nitric oxide--an important mediator in sepsis?]. Kirkebøen KA; Strand OA Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4061-5. PubMed ID: 10613098 [TBL] [Abstract][Full Text] [Related]
3. Overproduction of nitric oxide in pathophysiology of blood vessels. Stoclet JC; Muller B; Andriantsitohaina R; Kleschyov A Biochemistry (Mosc); 1998 Jul; 63(7):826-32. PubMed ID: 9721335 [TBL] [Abstract][Full Text] [Related]
4. Role of endogenous nitric oxide in septic shock. Vallance P; Moncada S New Horiz; 1993 Feb; 1(1):77-86. PubMed ID: 7922396 [TBL] [Abstract][Full Text] [Related]
5. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis. Jia YX; Pan CS; Yang JH; Liu XH; Yuan WJ; Zhao J; Tang CS; Qi YF Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1202-8. PubMed ID: 17184502 [TBL] [Abstract][Full Text] [Related]
6. Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide. Enkhbaatar P; Okajima K; Uchiba M; Isobe H; Okabe H Thromb Haemost; 2001 Dec; 86(6):1573-7. PubMed ID: 11776329 [TBL] [Abstract][Full Text] [Related]
7. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Wheatley C Med Hypotheses; 2006; 67(1):124-42. PubMed ID: 16545917 [TBL] [Abstract][Full Text] [Related]
8. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock. Iskit AB; Guc O Acta Pharmacol Sin; 2003 Oct; 24(10):953-7. PubMed ID: 14531935 [TBL] [Abstract][Full Text] [Related]
9. Cardiogenic shock: the role of inflammation. Shpektor A Acute Card Care; 2010 Dec; 12(4):115-8. PubMed ID: 21039083 [TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase in the liver: regulation and function. Taylor BS; Alarcon LH; Billiar TR Biochemistry (Mosc); 1998 Jul; 63(7):766-81. PubMed ID: 9721329 [TBL] [Abstract][Full Text] [Related]
11. [Impact of nitric oxide synthase 3 on myocardial dysfunction in sepsis]. Ichinose F Masui; 2008 Mar; 57(3):294-301. PubMed ID: 18340997 [TBL] [Abstract][Full Text] [Related]
12. [Nitric oxide--a basic mediator of vasodilation and septic shock]. Vasilev D; Karadimov D; Vogt J; Santak B Khirurgiia (Sofiia); 1996; 49(4):14-6. PubMed ID: 8968135 [TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in hemorrhagic shock-induced bacterial translocation. Hua TC; Moochhala SM J Surg Res; 2000 Oct; 93(2):247-56. PubMed ID: 11027467 [TBL] [Abstract][Full Text] [Related]
15. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock. Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821 [TBL] [Abstract][Full Text] [Related]
16. [Is use of nitric oxide (NO) synthase inhibitors justified for therapy of septic shock?]. Jonderko G; Marcisz C; Braclik M Postepy Hig Med Dosw; 2003; 57(1):67-90. PubMed ID: 12765124 [TBL] [Abstract][Full Text] [Related]
17. Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock. Pullamsetti SS; Maring D; Ghofrani HA; Mayer K; Weissmann N; Rosengarten B; Lehner M; Schudt C; Boer R; Grimminger F; Seeger W; Schermuly RT Thromb Haemost; 2006 Apr; 95(4):720-7. PubMed ID: 16601845 [TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Ichinose F; Buys ES; Neilan TG; Furutani EM; Morgan JG; Jassal DS; Graveline AR; Searles RJ; Lim CC; Kaneki M; Picard MH; Scherrer-Crosbie M; Janssens S; Liao R; Bloch KD Circ Res; 2007 Jan; 100(1):130-9. PubMed ID: 17138944 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR; Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555 [TBL] [Abstract][Full Text] [Related]
20. Involvement and dual effects of nitric oxide in septic shock. Wolkow PP Inflamm Res; 1998 Apr; 47(4):152-66. PubMed ID: 9628258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]